Last reviewed · How we verify
Randomisation to mepolizumab
Randomisation to mepolizumab is a Small molecule drug developed by Cliniques universitaires Saint-Luc- Université Catholique de Louvain. It is currently FDA-approved. Also known as: Active-controlled.
Mepolizumab is an interleukin-5 inhibitor, classified as an antibody, used to treat conditions such as asthma and severe asthma. It works by inhibiting interleukin-5, a cytokine involved in the growth and activation of eosinophils.
At a glance
| Generic name | Randomisation to mepolizumab |
|---|---|
| Also known as | Active-controlled |
| Sponsor | Cliniques universitaires Saint-Luc- Université Catholique de Louvain |
| Modality | Small molecule |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- Study of Magnitude and Prediction of Response to Omalizumab and Mepolizumab in Adult Severe Asthma. (PHASE4)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Randomisation to mepolizumab CI brief — competitive landscape report
- Randomisation to mepolizumab updates RSS · CI watch RSS
- Cliniques universitaires Saint-Luc- Université Catholique de Louvain portfolio CI
Frequently asked questions about Randomisation to mepolizumab
What is Randomisation to mepolizumab?
Who makes Randomisation to mepolizumab?
Is Randomisation to mepolizumab also known as anything else?
What development phase is Randomisation to mepolizumab in?
Related
- Manufacturer: Cliniques universitaires Saint-Luc- Université Catholique de Louvain — full pipeline
- Also known as: Active-controlled
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing